Lemaitre Vascular (LMAT) Non-Current Debt (2020 - 2021)
Lemaitre Vascular (LMAT) posted quarterly Non-Current Debt of $22.4 million for Q2 2021, down 39.31% year-over-year from $37.0 million in Q2 2020, and down 21.19% quarter-over-quarter from $28.5 million in Q1 2021.
Lemaitre Vascular (LMAT) Non-Current Debt (2020 - 2021) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Non-Current Debt for 2 consecutive years, with $22.4 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Non-Current Debt fell 39.31% year-over-year to $22.4 million; the TTM figure through Jun 2021 stood at $22.4 million (down 39.31% YoY), while the FY2020 annual figure was $35.5 million, changed N/A from the prior year.
- Non-Current Debt declined to $22.4 million in Q2 2021 per LMAT's latest filing, from $28.5 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $37.0 million in Q2 2020 and bottomed at $22.4 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.51 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 4.15 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 399.42 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 12.55 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.57 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.86 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 8.62 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 22.45 Mn |
| Mar 31, 2021 | 28.49 Mn |
| Dec 31, 2020 | 35.53 Mn |
| Sep 30, 2020 | 36.23 Mn |
| Jun 30, 2020 | 36.99 Mn |